Literature DB >> 1346879

Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s.

P P Cleary1, E L Kaplan, J P Handley, A Wlazlo, M H Kim, A R Hauser, P M Schlievert.   

Abstract

During the 1980s there was a resurgence of serious Streptococcus pyogenes infections with complications, including rheumatic fever, sepsis, severe soft-tissue invasion, and toxic-shock-like syndrome (TSLS). We have investigated the suggested association between expression of a scarlet fever toxin, SPE A, and systemic toxicity, and the possibility that a new highly virulent clone of S pyogenes has emerged and spread world wide. We studied serotype M1 strains, the serotype most commonly associated with serious complications. 19 isolates from patients with sepsis, with or without TSLS, and 48 from patients with uncomplicated pharyngitis or superficial skin infection were subjected to restriction-enzyme digestion and electrophoresis; 56 isolates (19 serious, 37 uncomplicated disease) were then examined by hybridisation to an speA gene probe. 17 (90%) of the 19 serious-disease isolates had a characteristic ("invasive", I) restriction-fragment profile and were positive for the speA gene. Significantly lower proportions of the isolates from patients with uncomplicated disease had the I profile (21/48 [44%]; p = 0.0035) and speA (20/37 [54%]; p less than 0.001). These findings suggest that the strains from patients with serious disease are a unique clone, which became the predominant cause of severe streptococcal infections in the United States and elsewhere in the late 1980s.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346879     DOI: 10.1016/0140-6736(92)90339-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  101 in total

1.  Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

Authors:  M Roggiani; J A Stoehr; S B Olmsted; Y V Matsuka; S Pillai; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  High-resolution genotyping of Streptococcus pyogenes serotype M1 isolates by fluorescent amplified-fragment length polymorphism analysis.

Authors:  M Desai; A Efstratiou; R George; J Stanley
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong.

Authors:  P L Ho; D R Johnson; A W Y Yue; D N C Tsang; T L Que; B Beall; E L Kaplan
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications.

Authors:  E L Kaplan; D R Johnson; P Nanthapisud; S Sirilertpanrana; S Chumdermpadetsuk
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

5.  Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002.

Authors:  Jing-Jou Yan; Ching-Chuan Liu; Wen-Chien Ko; Shui-Yuan Hsu; Hsiu-Mei Wu; Yee-Shin Lin; Ming T Lin; Woei-Jer Chuang; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

6.  Resurgence of virulent group A streptococcal infections - the streptococcal toxic shock syndrome.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1992-09

7.  Consumption of antibiotics in Sweden, 1975 to 1992: pharmacoeconomic and clinical aspects.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

8.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

9.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

10.  Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.

Authors:  S U Kazmi; R Kansal; R K Aziz; M Hooshdaran; A Norrby-Teglund; D E Low; A B Halim; M Kotb
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.